Almirall Announces Expanded CVS Caremark Coverage and New Clinical Data for Tirbanibulin at AAD 2026
Christopher Bunick, MD, PhD, and Almirall's Johnny Im discuss new data showing that tirbanibulin 1% ointment provides consistent efficacy, while expanded coverage is poised to improve patient access in the US.
